Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 14 trials

Late-Stage Pipeline

21%

3 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

6 recruiting

Enrollment Performance

Analytics

Early Phase 1
3(33.3%)
Phase 2
2(22.2%)
Phase 4
2(22.2%)
Phase 3
1(11.1%)
N/A
1(11.1%)
9Total
Early Phase 1(3)
Phase 2(2)
Phase 4(2)
Phase 3(1)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (14)

Showing 14 of 14 trials
NCT06741839Not ApplicableRecruiting

Confocal Laser Endomicroscopy Guided Medical Thoracoscopy for the Diagnosis of Pleural Disease

Role: collaborator

NCT04966793Recruiting

Microbial Colonization Distribution and Adaptive Evolution of Lower Respiratory Tract in Bronchiectasis Patients.

Role: collaborator

NCT07169903Phase 3Not Yet Recruiting

Segmentectomy vs Lobectomy for 2 - 3cm IASLC Grade 1-2 Lung Adenocarcinoma: A Multi-center RCT

Role: collaborator

NCT05979935Active Not Recruiting

A Digital Tongue Diagnosis Model for High- and Low-risk Esophagogastroduodenal Varices in Cirrhosis

Role: collaborator

NCT06709859Phase 2Recruiting

Afatinib Combined With Chemotherapy as Conversion Therapy in Unresectable EGFR Sensitive Mutation-positive Stage III NSCLC

Role: lead

NCT07066059Early Phase 1Not Yet Recruiting

Study on the Efficacy and Safety of Shouhui Tongbian Capsules in Protecting Intestine During the Perioperative Period

Role: collaborator

NCT06917495Phase 2Not Yet Recruiting

Short-Course Anti-tuberculosis Regimens for Mild Spinal Tuberculosis

Role: collaborator

NCT06711575Recruiting

Model-informed Individualized Treatment of Anti-Infective Drugs in Patients With Spinal Infections

Role: collaborator

NCT06673602Phase 4Recruiting

Fufang Congrong Yizhi Capsules (FCYC) of Cognitive Impairment After Intracerebral Hemorrhage

Role: collaborator

NCT06476210Phase 4Recruiting

The Safety and Efficacy of BDL(Bedaquiline Plus Delamanid Plus Linezolid) Regimen in Subjects With Pulmonary Infection of Multi-drug Resistant Tuberculosis (MDR-TB) or Rifampicin-Resistant Tuberculosis (RR-TB)

Role: collaborator

NCT05872659Early Phase 1Unknown

Mesenchymal Stem Cells for Immune Non-responder Patients With HIV Infection

Role: collaborator

NCT05802199Unknown

Quantitative Detection Efficiency of UDFF for Nonalcoholic Fatty Liver Disease

Role: collaborator

NCT04597346Unknown

Evaluate the Diagnostic Value of BTPNA for PPL: a Real-world Study

Role: collaborator

NCT05411757Early Phase 1Unknown

IBR900 Cell Injection Combined With Lenvatinib or Bevacizumab in the Treatment of Advanced Primary Liver Cancer

Role: lead

All 14 trials loaded